PuraMed BioScience, Inc. Appoints Former Quigley Corporation COO, Charles A. Phillips, to the Board of Directors
December 12, 2011 09:15 ET
|
PuraMed BioScience, Inc.
SCHOFIELD, Wis., Dec. 12, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience Inc. (OTCBB:PMBS) is pleased to announce the appointment of Charles A. Phillips to the Board of Directors. Phillips began his...
PuraMed BioScience Inc. Announces Initial Series of Purchase Orders for LipiGesic(R)M With 2nd Largest Drug Chain in the United States, CVS
December 06, 2011 09:15 ET
|
PuraMed BioScience, Inc.
SCHOFIELD, Wis., Dec. 6, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience Inc. (OTCBB:PMBS) announced today that it has received an initial series of purchase orders for its new over-the-counter migraine...
PuraMed BioScience, Inc. Announces LipiGesic(TM) M Now Available at Walgreens
November 28, 2011 09:15 ET
|
PuraMed BioScience, Inc.
SCHOFIELD, Wis., Nov. 28, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCBB:PMBS) announced today that their new non-prescription migraine medication, LipiGesic™ M, is now available for...
PuraMed BioScience, Inc. Achieves National Distribution With One of the Top Retailers in the United States
September 20, 2011 09:45 ET
|
PuraMed BioScience, Inc.
SCHOFIELD, Wis., Sept. 20, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) announced today that they have received the initial series of purchase orders with one of the top retailers in...
PuraMed BioScience, Inc. Selects Media Relations, Inc. to Handle Launch of Its New Migraine Treatment, LipiGesic M
August 15, 2011 11:50 ET
|
PuraMed BioScience, Inc.
MINNEAPOLIS, Aug. 15, 2011 (GLOBE NEWSWIRE) -- PuraMed BioSciences, Inc. (OTCQB:PMBS) has chosen Media Relations, Inc. to create consumer awareness and excitement nationally for LipiGesic M, the...
Top-Tier Medical Journal Headache Publishes in Print the Clinical Study Results of PuraMed BioScience, Inc. Revolutionary New Migraine Medication LipiGesic(TM) M
July 20, 2011 09:00 ET
|
PuraMed BioScience, Inc.
SCHOFIELD, Wis., July 20, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is announcing that an independent clinical study of its non-prescription migraine medication LipiGesic™ M...
Independent Clinical Study of PuraMed BioScience's Non-Prescription Migraine Medication LipiGesic(TM) M to be Presented at 2011 Headache Update Conference
July 11, 2011 09:00 ET
|
PuraMed BioScience, Inc.
SCHOFIELD, Wis., July 11, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is announcing that leading headache researcher Dr. Roger Cady, MD will be exhibiting a poster presentation...
Video Release -- Top-Tier Medical Journal Headache Publishes Clinical Study Results of PuraMed BioScience, Inc. Revolutionary New Migraine Medication LipiGesic(TM) M
June 02, 2011 12:22 ET
|
PuraMed BioScience, Inc.
SCHOFIELD, Wis., June 2, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is announcing that an independent clinical study of its non-prescription migraine medication LipiGesic™ M...
PuraMed BioScience, Inc. Pursues Initial Contact With Top National Retail Outlets to Introduce Non-Prescription Migraine Medication LipiGesic(TM) M
April 14, 2011 10:00 ET
|
PuraMed BioScience, Inc.
SCHOFIELD, Wis., April 14, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) is providing an update to its shareholders regarding the next steps in introducing its non-prescription...
Clinical Study of PuraMed BioScience, Inc. Product LipiGesic(TM) M Accepted for Publication in Top-Ranked Medical Journal
April 06, 2011 11:55 ET
|
PuraMed BioScience, Inc.
SCHOFIELD, Wis., April 6, 2011 (GLOBE NEWSWIRE) -- PuraMed BioScience, Inc. (OTCQB:PMBS) announced today that the independent clinical study of LipiGesic™ M has been accepted for publication in...